Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot P43246: Variant p.Pro622Leu

DNA mismatch repair protein Msh2
Gene: MSH2
Feedback?
Variant information Variant position: help 622 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change: help From Proline (P) to Leucine (L) at position 622 (P622L, p.Pro622Leu). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Similar physico-chemical property. Both residues are medium size and hydrophobic. The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help -3 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Variant description: help In LYNCH1; decreased mismatch repair activity; confers multiple biochemical defects. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 622 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 934 The length of the canonical sequence.
Location on the sequence: help LDAVVSFAHVSNGAPVPYVR P AILEKGQGRIILKASRHACV The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human                         LDAVVSFAHVSNGAPVPYVRPAIL-----EKGQG------------------------------RIILKASRHACV

Mouse                         LDAIVSFAHVSNAAPVPYVRPVIL-----EKGKG-------

Rat                           LDAVVSFAHVSNAAPVPYVRPVIL-----EKGKG-------

Bovine                        LDAVVSFAHVSDAAPVPYVRPVIL-----EKGRG-------

Drosophila                    LDCLVSFAIAARSAPTPYVRPKML-----EEGAR-------

Slime mold                    LDVFVTLSHVSSIAPIPFIRPEIIPLGSDENGAG-------

Baker's yeast                 LDVIASFAHTSSYAPIPYIRPKLHP----MDSER-------

Fission yeast                 LDVILSFAHASTVAVIPYVRPNIVDSSIAQEKHGQSSNILD

Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 2 – 934 DNA mismatch repair protein Msh2
Region 601 – 671 Interaction with EXO1



Literature citations
Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer.
Leach F.S.; Nicolaides N.C.; Papadopoulos N.; Liu B.; Jen J.; Parsons R.; Peltomaeki P.; Sistonen P.; Aaltonen L.A.; Nystroem-Lahti M.; Guan X.-Y.; Zhang J.; Meltzer P.S.; Yu J.-W.; Kao F.-T.; Chen D.J.; Cerosaletti K.M.; Fournier R.E.K.; Todd S.; Lewis T.; Leach R.J.; Naylor S.L.; Weissenbach J.; Mecklin J.-P.; Jaervinen H.; Petersen G.M.; Hamilton S.R.; Green J.; Jass J.; Watson P.; Lynch H.T.; Trent J.M.; de la Chapelle A.; Kinzler K.W.; Vogelstein B.;
Cell 75:1215-1225(1993)
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1); VARIANTS LYNCH1 LEU-622 AND TYR-639; Mutator phenotypes of common polymorphisms and missense mutations in MSH2.
Drotschmann K.; Clark A.B.; Kunkel T.A.;
Curr. Biol. 9:907-910(1999)
Cited for: CHARACTERIZATION OF VARIANTS ASP-322; PHE-390; LYS-419; TYR-506; PRO-524; LEU-622 AND PHE-697; Functional analysis of human MLH1 and MSH2 missense variants and hybrid human-yeast MLH1 proteins in Saccharomyces cerevisiae.
Ellison A.R.; Lofing J.; Bitter G.A.;
Hum. Mol. Genet. 10:1889-1900(2001)
Cited for: CHARACTERIZATION OF VARIANTS ASP-322; LEU-622 AND TYR-639; HNPCC mutations in hMSH2 result in reduced hMSH2-hMSH6 molecular switch functions.
Heinen C.D.; Wilson T.; Mazurek A.; Berardini M.; Butz C.; Fishel R.;
Cancer Cell 1:469-478(2002)
Cited for: VARIANTS LYNCH1 HIS-167; MET-393; PRO-524; ASN-596 DEL; LEU-622; SER-674 AND ARG-905; CHARACTERIZATION OF VARIANTS LYNCH1 HIS-167; MET-393; PRO-524; ASN-596 DEL; LEU-622; SER-674 AND ARG-905; Functional analysis of HNPCC-related missense mutations in MSH2.
Lutzen A.; de Wind N.; Georgijevic D.; Nielsen F.C.; Rasmussen L.J.;
Mutat. Res. 645:44-55(2008)
Cited for: CHARACTERIZATION OF VARIANTS LYNCH1 HIS-167; THR-305: LEU-622; ARG-639; ARG-674; PHE-697 AND THR-834;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.